Given that Pirfenidone is metabolised in the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is probably going to precipitate the toxicity of pirfenidone: concomitant therapy would be to be averted. Stay away from; coadministration of pirfenidone and moderate CYP1A2 inhibitors bring about reasonably amplified exposure to pirfenidone; if https://butylphthalide00886.suomiblog.com/little-known-facts-about-bzatp-triethylammonium-salt-45362364